| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |